SCHEMBL484824

SCHEMBL484824

COc1cc(C)c(C(=O)NC2CCc3ccc(C(=O)N4CCC5(CC4)CCN(c4cccnc4)CC5)cc32)c(C)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.45
CYP2D6 P10635 5/20 0.45
CYP1A2 P05177 4/20 0.45
ALDH1A1 P00352 6/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
USP2 O75604 4/20 0.45
MAPK1 P28482 4/20 0.42
HSD17B10 Q99714 3/20 0.42
TSHR P16473 2/20 0.42
LMNA P02545 1/20 0.42
WDR5 P61964 4/20 0.40
CYP2C9 P11712 6/20 0.40
HPGD P15428 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP2C19 P33261 2/20 0.39
HIF1A Q16665 3/20 0.39
ABL1 P00519 1/20 0.38
BCR P11274 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484665 0.91 CYP3A4 (0.57) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484292 0.87 CYP3A4 (0.53) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484115 0.87 CYP3A4 (0.51) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484621 0.86 USP2 (0.45) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484536 0.84 CYP3A4 (0.44) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484320 0.84 ALDH1A1 (0.43) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484924 0.84 CYP2C9 (0.52) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484437 0.83 CYP3A4 (0.59) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484782 0.82 BDKRB1 (0.39) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2
SCHEMBL484447 0.80 ALDH1A1 (0.41) CYP3A4CYP2D6CYP1A2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885CYP1A2 3400/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885CYP1A2 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.